Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

TCL - 352

ALK Status, Clinical Features, and Outcomes in Anaplastic Large Cell Lymphoma: Experience from a National Reference Center in Hispanic Population

Preview of ALK Status, Clinical Features, and Outcomes in Anaplastic Large Cell Lymphoma: Experience from a National Reference Center in Hispanic Population

View Poster Contact Presenter

Poster Presenter

Amairani Carpintero Diaz

Authors

Amairani Carpintero Diaz

Part of Topic

T-Cell Lymphoma (TCL)

ALK Status, Clinical Features, and Outcomes in Anaplastic Large Cell Lymphoma: Experience from a National Reference Center in Hispanic Population

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Other ePosters in

Topic

TCL - 002A Rare Case of ALK-negative Anaplastic T-Cell Lymphoma Arising in a Pros...

TCL - 054Laboratory Correlates and Response Patterns in Egyptian Patients With My... $Preview of Efficacy and Safety of Bispecific Antibodies in Relapsed/Refractory T-Cell Lymphoma: A Systematic Review and Single-Arm Meta-Analysis Focusing on Acimtamig (AFM13)$ TCL - 1043Efficacy and Safety of Bispecific Antibodies in Relapsed/Refractory T-Ce...

TCL - 1069Serum Proteomics Reveals Immunoproteomic Profile Distinguishing Early-St...

TCL - 1156Leukemia Subtype-Specific Patterns of Tumor Lysis Syndrome-Induced Acute...

ePosters in

Topics

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)